Developer docs
API playgroundTry for free, no card

Search company profiles

Mind Foundation

Full company profile

uuid02lkvo4

Namestring
Mind Foundation
Legal namestring
MIND Foundation gGmbH
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
psychedelic therapy training, psychiatric clinical research, mental health education, professional therapist certification, psychedelic science nonprofit
Industry4 codes
PRIMARYHSADAJAH
Meditation Apps, Digital Courses & Online Communities
SECONDARYEDAAAHAD
Mindfulness, Meditation & Stress Management Education
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)
SECONDARYHSADAJAB
Mindfulness-Based Coaching & Training (MBSR/MBCT-style)
SECONDARYHSADAGAG
Mind-Body Wellness Coaching (Holistic/Integrative)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Religious, Grantmaking, Civic, Professional, and Similar Organizations813
  • Offices of Mental Health Practitioners (except Physicians)621330
SIC code2 codes
  • Services-Engineering, Accounting, Research, Management8700
  • Services-Membership Organizations8600
Product category
Psychedelic therapy research and education
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Membership Fees
TypeSubscription Recurring
Description

Standard Membership at €12/month (€120/year) or Access Membership at €6/month (€60/year). Both tiers offer identical benefits. Membership fees are tax-deductible as the MIND Members Association (Förderverein MIND Foundation e.V.) is a registered charitable association under German law.

mind-foundation.org
2Training & Education Programs
TypeProfessional Services
Description

The Augmented Psychotherapy Training (APT) is a 15-month professional program in psychedelic therapy for health professionals, available in English and German. Additional programs include Molecules (self-paced online course), Beyond Experience (integration workshop), and Footsteps (online integration course). Participation fees apply.

mind-foundation.org
3Event Participation Fees
TypeOne Time License
Description

Revenue from INSIGHT Forum events, INSIGHT Conference, and uniMIND Symposium. Event fees support program delivery.

mind-foundation.org
4Donations & Philanthropic Funding
TypeSubscription Recurring
Description

Tax-deductible donations to the MIND Foundation gGmbH (recognized as charitable under German law). Donations via bank transfer or PayPal. The organization also receives government research grants (e.g., BMBF funding for the Acceptance Study).

mind-foundation.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details2 tiers
1Standard Membership - €12/month or €120/year
ModelSubscriptionBilling cadenceMonthly
Notes

Full rate for individuals able to contribute the full amount. Both Standard and Access memberships offer identical benefits including access to MCP, monthly Journal Clubs, Members Teach, Integration Circles, Meetups, and governance participation. Annual billing saves two months.

mind-foundation.org
2Access Membership - €6/month or €60/year
ModelSubscriptionBilling cadenceMonthly
Notes

Reduced rate for students, low-income individuals, or people in transitional life phases. Same benefits as Standard. Both monthly and annual billing available; annual saves two months.

mind-foundation.org
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 9 records shown
1uniMIND
Description

Global network of academic journal clubs exploring psychedelic research, open to students, researchers, and curious thinkers from all disciplines.

mind-foundation.org
+8 more records
Core offering1 text field

MIND Foundation is a non-profit research and education organization that delivers professional therapist training (Augmented Psychotherapy Training/APT, 15 months), online public courses on psychopharmacology and psychedelic integration (Molecules, Beyond Experience, Footsteps), and runs clinical research studies including Phase IIb and Phase III psilocybin trials. It also operates a global community ecosystem through the uniMIND journal club network (32 clubs), MIND Members Association (48+ countries), MIND Community Platform digital hub, and the INSIGHT Forum and INSIGHT Conference event series, alongside clinical partner OVID Clinic Berlin.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 192 health professionals enrolled or graduated from the APT psychedelic therapist training program
+3 more records
Product and service9 records
1Augmented Psychotherapy Training (APT)
CategoryProfessional training program
Description

A 15-month professional training program providing health professionals (doctors, psychiatrists, psychotherapists) with the knowledge and skills needed to practice psychedelic therapy in a legal, safe, and evidence-based framework.

2Molecules
CategoryOnline education course
Description

A self-paced online course exploring psychopharmacology in culture and society, available to the general public.

3Beyond Experience
CategoryIntegration workshop
Description

An integration workshop open to the general public for supporting reflection on psychedelic experiences.

4Footsteps
CategoryOnline education course
Description

An online integration course for personal development and psychedelic experience integration.

5uniMIND Journal Clubs
CategoryCommunity / academic program
Description

A global network of 32 academic journal clubs exploring psychedelic research, connecting students, researchers, and curious thinkers through regular meetings and the annual uniMIND Symposium.

6INSIGHT Forum
CategoryPublic event series
Description

A public talk series exploring psychedelics in medicine and culture of consciousness, featuring three segments: Rationale (intellectual discourse), Transrationale (experience-based practices), and Communitas (networking).

7INSIGHT Conference
CategoryConference
Description

An international, transdisciplinary conference series focused on research, therapy, and human development in relation to psychedelics, held biennially since 2019.

8MIND Community Platform (MCP)
CategoryDigital community platform
Description

A digital hub for MIND Members providing discussion spaces, networks (uniMIND Journal Clubs, APT Network, Integration Circles, Local Meetups), sections (Neuroscience, Mental Health, Resonance, Philosophy, Arts, Policy & Law), and educational material.

9MIND Members Association
CategoryMembership program
Description

A registered charitable association offering Standard Membership (€12/month or €120/year) and Access Membership (€6/month or €60/year), providing access to the MIND Community Platform, monthly Journal Clubs, Members Teach, Integration Circles, and Meetups.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
1INSIGHT Conference
Strategic tierFlagshipTypeOthersAnnounced on2024-02-15
Description

INSIGHT Conference is the largest conference on science and research into psychedelics in the German-speaking world, organized biennially by MIND Foundation since 2019. It is an international transdisciplinary conference covering research, therapy, and human development. The INSIGHT Forum event series is inspired by and connected to this conference.

mind-foundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

OVID Clinic Berlin is MIND Foundation's clinical partner — an outpatient and day clinic integrating guideline therapies with novel psychedelic treatments. It is Europe's first psychedelic day clinic. Together they form a care ecosystem transforming mental health from treatment to growth. OVID Clinic also serves as a clinical trial site for psychedelic studies, and Dr. Henrik Jungaberle (CEO of MIND) is co-founder of OVID.

3Zentralinstitut für Seelische Gesundheit (ZI Mannheim)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Zentralinstitut für Seelische Gesundheit in Mannheim led the EPIsoDE Phase IIb clinical trial (144 patients, completed) investigating psilocybin for treatment-resistant depression, in cooperation with Charité Berlin and MIND Foundation. ZI Mannheim is also a consortium partner in the DiMension Phase III trial, which would be the largest psychedelic study ever conducted.

mind-foundation.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Charité Universitätsmedizin Berlin co-led the EPIsoDE Phase IIb clinical trial on psilocybin for treatment-resistant depression alongside ZI Mannheim and MIND Foundation. The trial was the largest publicly funded psilocybin study to date.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

SPRIN-D (German Federal Agency for Breakthrough Innovation) is a consortium partner in the DiMension Phase III clinical trial. The consortium aims to conduct the largest psychedelic study ever (700+ patients) and obtain regulatory approval and public reimbursement for psilocybin-assisted therapy in Europe.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Usona Institute is a consortium partner in the DiMension Phase III clinical trial alongside MIND Foundation, SPRIN-D, and ZI Mannheim. Usona is a non-profit psychedelic research organization working to advance psilocybin-based therapies through clinical trials and regulatory approval.

7BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Strategic tierCoreTypeOthers
Description

BfArM has authorized clinical trials at OVID Clinic Berlin for psychedelic substances on the pathway to drug approval, including studies on depression (5-MeO-DMT) and generalized anxiety disorder (LSD derivative).

mind-foundation.org
8Essence Institute (Netherlands)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Dr. Sepideh Ravahi, a board member of the MIND Members Association, collaborates with the Essence Institute in the Netherlands where she facilitates legal psilocybin retreats. This represents a personal/professional connection rather than an institutional partnership.

mind-foundation.org
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Market position
Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mind Foundation

Psychedelic therapy research and educationmind-foundation.org

Mind Foundation firmographics

Firmographics
Name
Mind Foundation
Legal name
MIND Foundation gGmbH
Website
https://mind-foundation.org
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Mind Foundation industry classification

Industry
Product category
Psychedelic therapy research and education
NAICS
Scientific Research and Development Services (5417), Religious, Grantmaking, Civic, Professional, and Similar Organizations (813), Offices of Mental Health Practitioners (except Physicians) (621330)
SIC
Services-Engineering, Accounting, Research, Management (8700), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYHSADAJAH
Meditation Apps, Digital Courses & Online Communities
SECONDARYEDAAAHAD
Mindfulness, Meditation & Stress Management Education
Education/Adult & Continuing Education/Health, Wellness & Lifestyle Education (Nutrition, Fitness, Mindfulness)
SECONDARYHSADAJAB
Mindfulness-Based Coaching & Training (MBSR/MBCT-style)
SECONDARYHSADAGAG
Mind-Body Wellness Coaching (Holistic/Integrative)

Keywords

  • Psychedelic therapy training
  • Psychiatric clinical research
  • Mental health education
  • Professional therapist certification
  • Psychedelic science nonprofit

Where Mind Foundation is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Mind Foundation business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Membership Fees: Standard Membership at €12/month (€120/year) or Access Membership at €6/month (€60/year). Both tiers offer identical benefits. Membership fees are tax-deductible as the MIND Members Association (Förderverein MIND Foundation e.V.) is a registered charitable association under German law.
  2. Training & Education Programs: The Augmented Psychotherapy Training (APT) is a 15-month professional program in psychedelic therapy for health professionals, available in English and German. Additional programs include Molecules (self-paced online course), Beyond Experience (integration workshop), and Footsteps (online integration course). Participation fees apply.
  3. Event Participation Fees: Revenue from INSIGHT Forum events, INSIGHT Conference, and uniMIND Symposium. Event fees support program delivery.
  4. Donations & Philanthropic Funding: Tax-deductible donations to the MIND Foundation gGmbH (recognized as charitable under German law). Donations via bank transfer or PayPal. The organization also receives government research grants (e.g., BMBF funding for the Acceptance Study).

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyStandard Membership - €12/month or €120/year
SubscriptionMonthlyAccess Membership - €6/month or €60/year

Go-to-market motion1 record

Distribution channels5 records

Marketing channels9 records

Mind Foundation product offering

Product offering

Core offering

MIND Foundation is a non-profit research and education organization that delivers professional therapist training (Augmented Psychotherapy Training/APT, 15 months), online public courses on psychopharmacology and psychedelic integration (Molecules, Beyond Experience, Footsteps), and runs clinical research studies including Phase IIb and Phase III psilocybin trials. It also operates a global community ecosystem through the uniMIND journal club network (32 clubs), MIND Members Association (48+ countries), MIND Community Platform digital hub, and the INSIGHT Forum and INSIGHT Conference event series, alongside clinical partner OVID Clinic Berlin.

Differentiator

Problem solved

Functional benefit

Brands

  • uniMIND: Global network of academic journal clubs exploring psychedelic research, open to students, researchers, and curious thinkers from all disciplines.
  • INSIGHT Forum
  • INSIGHT Conference
  • Augmented Psychotherapy Training (APT)
  • Molecules
  • Beyond Experience
  • Footsteps
  • MIND Community Platform (MCP)
  • MIND Members Association

Products and services

  • Augmented Psychotherapy Training (APT) A 15-month professional training program providing health professionals (doctors, psychiatrists, psychotherapists) with the knowledge and skills needed to practice psychedelic therapy in a legal, safe, and evidence-based framework.
  • Molecules A self-paced online course exploring psychopharmacology in culture and society, available to the general public.
  • Beyond Experience An integration workshop open to the general public for supporting reflection on psychedelic experiences.
  • Footsteps An online integration course for personal development and psychedelic experience integration.
  • uniMIND Journal Clubs A global network of 32 academic journal clubs exploring psychedelic research, connecting students, researchers, and curious thinkers through regular meetings and the annual uniMIND Symposium.
  • INSIGHT Forum A public talk series exploring psychedelics in medicine and culture of consciousness, featuring three segments: Rationale (intellectual discourse), Transrationale (experience-based practices), and Communitas (networking).
  • INSIGHT Conference An international, transdisciplinary conference series focused on research, therapy, and human development in relation to psychedelics, held biennially since 2019.
  • MIND Community Platform (MCP) A digital hub for MIND Members providing discussion spaces, networks (uniMIND Journal Clubs, APT Network, Integration Circles, Local Meetups), sections (Neuroscience, Mental Health, Resonance, Philosophy, Arts, Policy & Law), and educational material.
  • MIND Members Association A registered charitable association offering Standard Membership (€12/month or €120/year) and Access Membership (€6/month or €60/year), providing access to the MIND Community Platform, monthly Journal Clubs, Members Teach, Integration Circles, and Meetups.

Quantifiable outcome

  • 192 health professionals enrolled or graduated from the APT psychedelic therapist training program
  • +3 more outcomes

Companies that use Mind Foundation

Customer profile

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Mind Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature2 records

Mind Foundation partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

  • INSIGHT ConferenceflagshipOthers · 15 February 2024INSIGHT Conference is the largest conference on science and research into psychedelics in the German-speaking world, organized biennially by MIND Foundation since 2019. It is an international transdisciplinary conference covering research, therapy, and human development. The INSIGHT Forum event series is inspired by and connected to this conference.
  • OVID Clinic BerlincoreStrategic or Co-development PartnerOVID Clinic Berlin is MIND Foundation's clinical partner — an outpatient and day clinic integrating guideline therapies with novel psychedelic treatments. It is Europe's first psychedelic day clinic. Together they form a care ecosystem transforming mental health from treatment to growth. OVID Clinic also serves as a clinical trial site for psychedelic studies, and Dr. Henrik Jungaberle (CEO of MIND) is co-founder of OVID.
  • Zentralinstitut für Seelische Gesundheit (ZI Mannheim)coreStrategic or Co-development PartnerZentralinstitut für Seelische Gesundheit in Mannheim led the EPIsoDE Phase IIb clinical trial (144 patients, completed) investigating psilocybin for treatment-resistant depression, in cooperation with Charité Berlin and MIND Foundation. ZI Mannheim is also a consortium partner in the DiMension Phase III trial, which would be the largest psychedelic study ever conducted.
  • Charité – Universitätsmedizin BerlincoreStrategic or Co-development PartnerCharité Universitätsmedizin Berlin co-led the EPIsoDE Phase IIb clinical trial on psilocybin for treatment-resistant depression alongside ZI Mannheim and MIND Foundation. The trial was the largest publicly funded psilocybin study to date.
  • SPRIN-D (Bundesagentur für Sprunginnovationen)flagshipStrategic or Co-development PartnerSPRIN-D (German Federal Agency for Breakthrough Innovation) is a consortium partner in the DiMension Phase III clinical trial. The consortium aims to conduct the largest psychedelic study ever (700+ patients) and obtain regulatory approval and public reimbursement for psilocybin-assisted therapy in Europe.
  • Usona InstituteflagshipStrategic or Co-development PartnerUsona Institute is a consortium partner in the DiMension Phase III clinical trial alongside MIND Foundation, SPRIN-D, and ZI Mannheim. Usona is a non-profit psychedelic research organization working to advance psilocybin-based therapies through clinical trials and regulatory approval.
  • BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)coreOthersBfArM has authorized clinical trials at OVID Clinic Berlin for psychedelic substances on the pathway to drug approval, including studies on depression (5-MeO-DMT) and generalized anxiety disorder (LSD derivative).
  • Essence Institute (Netherlands)minorStrategic or Co-development PartnerDr. Sepideh Ravahi, a board member of the MIND Members Association, collaborates with the Essence Institute in the Netherlands where she facilitates legal psilocybin retreats. This represents a personal/professional connection rather than an institutional partnership.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Mind Foundation competitors and assessment

Company assessment

Market position

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Mind Foundation social profiles

Digital presence

Mind Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mind Foundation leadership team

Management profile

Number of profiles

Profiles4 records

Mind Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mind Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mind Foundation

What does Mind Foundation do?

MIND Foundation is a non-profit research and education organization that delivers professional therapist training (Augmented Psychotherapy Training/APT, 15 months), online public courses on psychopharmacology and psychedelic integration (Molecules, Beyond Experience, Footsteps), and runs clinical research studies including Phase IIb and Phase III psilocybin trials. It also operates a global community ecosystem through the uniMIND journal club network (32 clubs), MIND Members Association (48+ countries), MIND Community Platform digital hub, and the INSIGHT Forum and INSIGHT Conference event series, alongside clinical partner OVID Clinic Berlin.

Is Mind Foundation a public or private company?

Mind Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Mind Foundation founded?

Mind Foundation was founded in 2016. It employs 51 to 100 people.

Where is Mind Foundation based?

Mind Foundation is headquartered in Berlin, Germany, in the Europe region.

How does Mind Foundation make money?

Four revenue lines are on record. Membership Fees are the primary driver. The others are training & Education Programs, event Participation Fees and donations & Philanthropic Funding.

Does Mind Foundation have an API?

No public API is recorded for Mind Foundation.

What industry is Mind Foundation in?

Mind Foundation's product category is Psychedelic therapy research and education. Its primary akta.pro industry code is HSADAJAH, Meditation Apps, Digital Courses & Online Communities, with a secondary code of EDAAAHAD, Mindfulness, Meditation & Stress Management Education. Its NAICS code is 5417 and its SIC code is 8700.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales